View DividendBlack Titan マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報Shang Lin最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間less than a year経営陣の近況Board Change • Nov 18High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Gabriel Loh is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Nov 13Black Titan Corporation Appoints Czhang Lin as Co Chief Executive OfficerBlack Titan Corporation announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment committee for Lbank Labs. Mr. Lin has been instrumental in identifying early-stage opportunities and driving institutional adoption of blockchain technologies. In his new role as Co-CEO, Mr. Lin will lead Black Titans crypto strategy, focusing on strategic investments in digital currencies, direct token acquisitions, blockchain infrastructure, mining operations, and fintech-related mergers and acquisitions. He will work closely with the executive team to position Black Titan at the forefront of the evolving digital asset landscape and unlock long-term value for shareholders. His appointment marks the next step in broader strategy to build a diversified digital asset portfolio and capture opportunities in a rapidly maturing market.すべての更新を表示Recent updatesNew Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (47% accrual ratio). Market cap is less than US$10m (US$6.65m market cap). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Share price has been volatile over the past 3 months (12% average weekly change). Revenue is less than US$5m (US$2.7m revenue).Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$1.50, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 20x in the IT industry in the US.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$1.55, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 19x in the IT industry in the US.New Risk • Mar 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.60m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (47% accrual ratio). Market cap is less than US$10m (US$9.60m market cap). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Revenue is less than US$5m (US$2.7m revenue).Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 37%After last week's 37% share price gain to US$2.35, the stock trades at a trailing P/E ratio of 44.5x. Average trailing P/E is 27x in the IT industry in the US.New Risk • Jan 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended January 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (47% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Revenue is less than US$5m (US$2.7m revenue). Market cap is less than US$100m (US$12.6m market cap).Valuation Update With 7 Day Price Move • Dec 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$1.77, the stock trades at a trailing P/E ratio of 33.5x. Average trailing P/E is 30x in the IT industry in the US.Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 23%After last week's 23% share price gain to US$4.12, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 31x in the IT industry in the US.New Risk • Nov 20New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 47% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). High level of non-cash earnings (47% accrual ratio). Minor Risks Revenue is less than US$5m (US$2.7m revenue). Market cap is less than US$100m (US$23.1m market cap).Board Change • Nov 18High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Gabriel Loh is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Nov 13Black Titan Corporation Appoints Czhang Lin as Co Chief Executive OfficerBlack Titan Corporation announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment committee for Lbank Labs. Mr. Lin has been instrumental in identifying early-stage opportunities and driving institutional adoption of blockchain technologies. In his new role as Co-CEO, Mr. Lin will lead Black Titans crypto strategy, focusing on strategic investments in digital currencies, direct token acquisitions, blockchain infrastructure, mining operations, and fintech-related mergers and acquisitions. He will work closely with the executive team to position Black Titan at the forefront of the evolving digital asset landscape and unlock long-term value for shareholders. His appointment marks the next step in broader strategy to build a diversified digital asset portfolio and capture opportunities in a rapidly maturing market.お知らせ • Oct 03Ke Sdn. Bhd. completed the acquisition of Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) in a reverse merger transaction.Ke Sdn. Bhd. entered into an agreement to acquire Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) for $21.6 million in a reverse merger transaction on August 19, 2024. Upon completion of the merger, the existing security holders of Ke Sdn. Bhd. ("KE") and Titan (excluding The Sire Group Ltd. and current Titan directors and officers) expect to own approximately 86.7% and 13.3%, respectively, of the outstanding shares of the combined company. It is expected that Dato’ Seow Gim Shen will own 48.9% of the outstanding shares of the combined company following the merger. Completion of the merger is subject to the approval of the merger by Titan’s stockholders, the registration statement shall have become effective, shares to be issued in connection with the transaction shall have been approved for listing on Nasdaq and satisfaction or waiver of other customary conditions. The agreement was unanimously approved by Titan’s board of directors. KE board of directors also approved the transaction. As of June 3, 2025, the transaction is expected to close in the third quarter of 2025. As of August 26, 2025, Titan Pharmaceuticals approved the transaction. Kenneth Schlesinger and Claudia Dubon of Olshan Frome Wolosky LLP acted as legal advisor to Titan Pharmaceuticals, Inc. Mitchell S. Nussbaum of Loeb & Loeb LLP acted as legal advisor to KE Sdn Bhd. Ke Sdn. Bhd. completed the acquisition of Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) in a reverse merger transaction on October 1, 2025. As a result of the Merger, it is anticipated that shares of TTNP common stock will cease trading on the Nasdaq Capital Market (“ Nasdaq ”) and PubCo Ordinary Shares will begin trading on Nasdaq commencing with the opening of trading on Thursday, October 2, 2025. TTNP’s directors and officers offered their resignations for serving in such capacities, at the request of Black Titan and not because of any disagreement with TTNP regarding any matter related to TTNP’s operations, policies or practices, and Chay Weei Jye was appointed as the sole director and acting secretary of TTNP.CEOShang Lin no data在職期間Mr. Shang Ju Lin was Co-Chief Executive Officer of Black Titan Corporation from November 2025 and serves as Chief Executive Officer.取締役名称ポジション在職期間報酬所有権Brynner ChiamCFO & Directorless than a yearデータなしデータなしFirdauz Bin MokhtarIndependent Directorless than a yearデータなしデータなしAvraham Ben-TzviIndependent Directorless than a yearデータなし0.045% $ 2.6kFrancisco Osvaldo GarcíaIndependent Directorless than a yearデータなしデータなしGabriel LohIndependent Directorless than a yearデータなしデータなしもっと見る0.7yrs平均在職期間48yo平均年齢経験豊富なボード: BTTCの 取締役会 は 経験豊富 ではない ( 0.7年の平均在任期間) ため、新しい取締役会が必要であると考えられます。View Ownership企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/24 16:29終値2026/06/24 00:00収益2025/01/31年間収益2024/07/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Black Titan Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • Nov 18High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Gabriel Loh is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Nov 13Black Titan Corporation Appoints Czhang Lin as Co Chief Executive OfficerBlack Titan Corporation announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment committee for Lbank Labs. Mr. Lin has been instrumental in identifying early-stage opportunities and driving institutional adoption of blockchain technologies. In his new role as Co-CEO, Mr. Lin will lead Black Titans crypto strategy, focusing on strategic investments in digital currencies, direct token acquisitions, blockchain infrastructure, mining operations, and fintech-related mergers and acquisitions. He will work closely with the executive team to position Black Titan at the forefront of the evolving digital asset landscape and unlock long-term value for shareholders. His appointment marks the next step in broader strategy to build a diversified digital asset portfolio and capture opportunities in a rapidly maturing market.
New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (47% accrual ratio). Market cap is less than US$10m (US$6.65m market cap). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Share price has been volatile over the past 3 months (12% average weekly change). Revenue is less than US$5m (US$2.7m revenue).
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$1.50, the stock trades at a trailing P/E ratio of 28.4x. Average trailing P/E is 20x in the IT industry in the US.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 20%After last week's 20% share price gain to US$1.55, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 19x in the IT industry in the US.
New Risk • Mar 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$9.60m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (47% accrual ratio). Market cap is less than US$10m (US$9.60m market cap). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Revenue is less than US$5m (US$2.7m revenue).
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 37%After last week's 37% share price gain to US$2.35, the stock trades at a trailing P/E ratio of 44.5x. Average trailing P/E is 27x in the IT industry in the US.
New Risk • Jan 19New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended January 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). High level of non-cash earnings (47% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported January 2025 fiscal period end). Revenue is less than US$5m (US$2.7m revenue). Market cap is less than US$100m (US$12.6m market cap).
Valuation Update With 7 Day Price Move • Dec 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to US$1.77, the stock trades at a trailing P/E ratio of 33.5x. Average trailing P/E is 30x in the IT industry in the US.
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 23%After last week's 23% share price gain to US$4.12, the stock trades at a trailing P/E ratio of 78x. Average trailing P/E is 31x in the IT industry in the US.
New Risk • Nov 20New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 47% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). High level of non-cash earnings (47% accrual ratio). Minor Risks Revenue is less than US$5m (US$2.7m revenue). Market cap is less than US$100m (US$23.1m market cap).
Board Change • Nov 18High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Gabriel Loh is the most experienced director on the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Nov 13Black Titan Corporation Appoints Czhang Lin as Co Chief Executive OfficerBlack Titan Corporation announced the appointment of Czhang Lin as Co-Chief Executive Officer, further strengthening the Company's leadership team as it accelerates its strategic expansion into the digital asset and blockchain sectors. Mr. Lin brings deep expertise in the cryptocurrency and blockchain ecosystem, with a track record of investing in and advising high-growth Web3 projects around the world since 2017. He has collected a vast network over the last 8 years by investing in projects or taking key roles in various funds, that include Binance labs and now currently serves as investment committee for Lbank Labs. Mr. Lin has been instrumental in identifying early-stage opportunities and driving institutional adoption of blockchain technologies. In his new role as Co-CEO, Mr. Lin will lead Black Titans crypto strategy, focusing on strategic investments in digital currencies, direct token acquisitions, blockchain infrastructure, mining operations, and fintech-related mergers and acquisitions. He will work closely with the executive team to position Black Titan at the forefront of the evolving digital asset landscape and unlock long-term value for shareholders. His appointment marks the next step in broader strategy to build a diversified digital asset portfolio and capture opportunities in a rapidly maturing market.
お知らせ • Oct 03Ke Sdn. Bhd. completed the acquisition of Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) in a reverse merger transaction.Ke Sdn. Bhd. entered into an agreement to acquire Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) for $21.6 million in a reverse merger transaction on August 19, 2024. Upon completion of the merger, the existing security holders of Ke Sdn. Bhd. ("KE") and Titan (excluding The Sire Group Ltd. and current Titan directors and officers) expect to own approximately 86.7% and 13.3%, respectively, of the outstanding shares of the combined company. It is expected that Dato’ Seow Gim Shen will own 48.9% of the outstanding shares of the combined company following the merger. Completion of the merger is subject to the approval of the merger by Titan’s stockholders, the registration statement shall have become effective, shares to be issued in connection with the transaction shall have been approved for listing on Nasdaq and satisfaction or waiver of other customary conditions. The agreement was unanimously approved by Titan’s board of directors. KE board of directors also approved the transaction. As of June 3, 2025, the transaction is expected to close in the third quarter of 2025. As of August 26, 2025, Titan Pharmaceuticals approved the transaction. Kenneth Schlesinger and Claudia Dubon of Olshan Frome Wolosky LLP acted as legal advisor to Titan Pharmaceuticals, Inc. Mitchell S. Nussbaum of Loeb & Loeb LLP acted as legal advisor to KE Sdn Bhd. Ke Sdn. Bhd. completed the acquisition of Titan Pharmaceuticals, Inc. (NasdaqCM:TTNP) in a reverse merger transaction on October 1, 2025. As a result of the Merger, it is anticipated that shares of TTNP common stock will cease trading on the Nasdaq Capital Market (“ Nasdaq ”) and PubCo Ordinary Shares will begin trading on Nasdaq commencing with the opening of trading on Thursday, October 2, 2025. TTNP’s directors and officers offered their resignations for serving in such capacities, at the request of Black Titan and not because of any disagreement with TTNP regarding any matter related to TTNP’s operations, policies or practices, and Chay Weei Jye was appointed as the sole director and acting secretary of TTNP.